AdvaMed has stepped up calls for a repeal of the 2.3% medical device tax in light of a final rule released Wednesday by the IRS. AdvaMed President Stephen Ubl said his group is carefully evaluating the final rule, but he sounded alarm over a potential "innovation cliff," loss of about 43,000 jobs and other repercussions if the tax is allowed to take effect next month.